IRF2 and acute myeloid leukemia: For example, miR222-3p, which is highly expressed in BMMSC-EVs, suppresses acute myeloid leukemia (AML) cell proliferation and promotes apoptosis by targeting the IRF2/INPP4B signaling pathway [143].